The β-blocker propranolol affects cAMP-dependent signaling and induces the stress response in Mediterranean mussels, Mytilus galloprovincialis

Aquatic Toxicology

Volumn 101, Issue 2, 2011, Pages 299-308

  Franzellitti, Silvia ^a   Buratti, Sara ^a   Valbonesi, Paola ^a   Capuzzo, Antonio ^b   Fabbri, Elena ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF FERRARA   (Italy)

Author keywords

Antioxidant response; CAMP; Lysosome membrane stability; Mytilus galloprovincialis; P glycoprotein gene expression; PKA activity; Propranolol

Indexed keywords

BETA ADRENERGIC RECEPTOR; CATALASE; CYCLIC AMP; GLUTATHIONE TRANSFERASE; GLYCOPROTEIN P; PROPRANOLOL;

ANTIOXIDANT; BIOMARKER; CONCENTRATION (COMPOSITION); DRUG; ECOTOXICOLOGY; GENE EXPRESSION; HOMOLOGY; MEMBRANE; MOLLUSC; RNA; SIGNALING;

ARTICLE; BIOLOGICAL MONITORING; CONTROLLED STUDY; CORRELATION ANALYSIS; DETOXIFICATION; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL STRESS; ENZYME ACTIVITY; EXOCRINE GLAND; LYSOSOME; MYTILUS GALLOPROVINCIALIS; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; STRESS; WATER POLLUTION;

ANIMALS; BIOLOGICAL MARKERS; CATALASE; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DIGESTIVE SYSTEM; GILLS; GLUTATHIONE TRANSFERASE; GONADS; HEMOCYTES; LYSOSOMES; MYTILUS; P-GLYCOPROTEIN; PROPRANOLOL; RECEPTORS, ADRENERGIC, BETA; WATER POLLUTANTS, CHEMICAL;

ANIMALIA; BIVALVIA; MAMMALIA; MYTILUS GALLOPROVINCIALIS;

EID: 78649577545     PISSN: 0166445X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.aquatox.2010.11.001     Document Type: Article

References (51)

1. Ashton D., Hilton M., Thomas K.V. Investigating the environmental transport of human pharmaceuticals to streams in the United Kingdom. Sci. Total Environ. 2004, 333:167-184.
2. Bachmakov I., Werner U., Endress B., Auge D., Fromm M.F. Characterization of beta-adrenoceptor antagonists as substrates and inhibitors of the drug transporter P-glycoprotein. Fundam. Clin. Pharmacol. 2006, 20:273-282.
3. Bard S.M. Multixenobiotic resistance as a cellular defense mechanism in aquatic organisms. Aquat. Toxicol. 2000, 48:357-389.
4. Cao J., Fernandez M., Vazquez-Illanes M.D., Ramos-Martinez J.I., Villamarin J.A. Purification and characterization of the catalytic subunit of cAMP-dependent protein kinase from the bivalve mollusc Mytilus galloprovincialis. Comp. Biochem. Physiol. B 1995, 111:453-462.
5. Cao J., Ramos-Martinez J.I., Villamarin J.A. Characterization of a cAMP-binding protein from the bivalve mollusc Mytilus galloprovincialis. Eur. J. Biochem. 1995, 232:664-670.
6. Christen V., Hickmann S., Rechenberg B., Fent K. Highly active human pharmaceuticals in aquatic systems: a concept for their identification based on their mode of action. Aquat. Toxicol. 2010, 96:167-181.
7. Contardo-Jara V., Pflugmacher S., Nützmann G., Kloas W., Wiegand C. The beta-receptor blocker metoprolol alters detoxification processes in the non-target organism Dreissena polymorpha. Environ. Pollut. 2010, 158:2059-2066.
8. Cubero-Leon E., Ciocan C.M., Hill E.M., Osada M., Kishida M., Itoh N., Kondo R., Minier C., Rotchell J.M. Estrogens disrupt serotonin receptor and cyclooxygenase mRNA expression in the gonads of mussels (Mytilus edulis). Aquat. Toxicol. 2010, 98:178-187.
9. Dailianis S., Domouhtsidou G.P., Raftopoulou E., Kaloyianni M., Dimitridis V.K. Evaluation of neutral red retention assay, micronucleus test, acetylcholinesterase activity and a signal transduction molecule (cAMP) in tissues of Mytilus galloprovincialis (L.), in pollution monitoring. Mar. Environ. Res. 2003, 56:443-470.
10. + exchanger and PKC. Free Radical Res. 2005, 39:1059-1070.
11. Dorne J.L.C.M., Skinner L., Frampton G.K., Spurgeon D.J., Ragas A.M.J. Human and environmental risk assessment of pharmaceuticals: differences, similarities, lessons from toxicology. Anal. Bioanal. Chem. 2007, 387:1259-1268.
12. Dzialowski E.M., Turner P.K., Brooks B.W. Physiological and reproductive effects of beta adrenergic receptor antagonists in Daphnia magna. Arch. Environ. Contam. Toxicol. 2006, 50:503-510.
13. Ericson H., Thorsén G., Kumblad L. Physiological effects of diclofenac, ibuprofen and propranolol on Baltic Sea blue mussels. Aquat. Toxicol. 2010, 99:223-231.
14. Fabbri E., Brighenti L., Ottolenghi C., Puviani A.C., Capuzzo A. β-Adrenergic receptors in catfish liver membranes: characterization and coupling to adenylate cyclase. Gen. Comp. Endocrinol. 1992, 85:254-260.
15. 2+. Aquat. Toxicol. 2006, 76:59-68.
16. Fabbri E., Capuzzo A. Cyclic AMP signaling in bivalve molluscs: an overview. J. Exp. Zool. A 2010, 313:179-200.
17. Fent K., Weston A.A., Caminada D. Ecotoxicology of human pharmaceuticals. Aquat. Toxicol. 2006, 76:122-159.
18. +. Biochem. Biophys. Res. Commun. 2006, 351:719-725.
19. Franzellitti S., Buratti S., Donnini F., Fabbri E. Exposure of mussels to a polluted environment: insights into the stress syndrome development. Comp. Biochem. Physiol. C 2010, 152:24-33.
20. Gagnè F., Blaise C., Andrè C., Gagnon C., Salazar M. Neuroendocrine disruption and health effects in Elliptio complanata mussels exposed to aeration lagoons for wastewater treatment. Chemosphere 2007, 68:731-743.
21. Garnerot F., Pellerin J., Blaise C., Mathieu M. Immunohistochemical localization of serotonin (5-hydroxytryptamine) in the gonad and digestive gland of Mya arenaria (Mollusca: Bivalvia). Gen. Comp. Endocrinol. 2006, 149:278-284.
22. Giltrow E., Eccles P.D., Winter M.J., McCormack P.J., Rand-Weaver M., Hutchinson T.H., Sumpter J.P. Chronic effects assessment and plasma concentrations of the beta-blocker propranolol in fathead minnows (Pimephales promelas). Aquat. Toxicol. 2009, 95:195-202.
23. Gomes A., Costa D., Lima J.L., Fernandes E. Antioxidant activity of beta-blockers: an effect mediated by scavenging reactive oxygen and nitrogen species?. Bioorg. Med. Chem. 2006, 14:4568-4577.
24. Huggett D.B., Brooks B.W., Peterson B., Foran C.M., Schlenk D. Toxicity of selected beta adrenergic receptor-blocking pharmaceuticals (β-blockers) on aquatic organisms. Arch. Environ. Contam. Toxicol. 2002, 43:229-235.
25. Kim J.W., Ishibashi H., Yamauchi R., Ichikawa N., Takao Y., Hirano M., Koga M., Arizono K. Acute toxicity of pharmaceutical and personal care products on freshwater crustacean (Thamnocephalus platyurus) and fish (Oryzias latipes). J. Toxicol. Sci. 2009, 34:227-232.
26. + exchanger (NHE) activation by ROS. Aquat. Toxicol. 2006, 78:315-324.
27. Lacoste A., Malham S.K., Cueff A., Poulet S.A. Noradrenaline modulates oyster hemocyte phagocytosis via a β-adrenergic receptor-cAMP signaling pathway. Gen. Comp. Endocrinol. 2001, 122:252-259.
28. Laville N., Aït-Aïssa S., Gomez E., Casellas C., Porcher J.M. Effects of human pharmaceuticals on cytotoxicity. EROD activity and ROS production in fish hepatocytes. Toxicology 2004, 196:41-55.
29. Lowry O.H., Rosenbrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 1951, 193:265-275.
30. Martin-Diaz M.L., Franzellitti S., Buratti S., Valbonesi P., Capuzzo A., Fabbri E. Effects of environmental concentrations of the antiepileptic drug carbamazepine on biomarkers and cAMP-mediated cell signaling in the mussel Mytilus galloprovincialis. Aquat. Toxicol. 2009, 94:177-185.
31. Martinez-Gomez C., Benedicto J., Campillo J.A., Moore M. Application and evaluation of the neutral red retention (NRR) assay for lysosomal stability in mussel populations along the Iberian Mediterranean coast. J. Environ. Monit. 2008, 10:490-499.
32. Minh T.B., Leung H.W., Loi I.H., Chan W.H., So M.K., Mao J.Q., Choi D., Lam J.C., Zheng G., Martin M., Lee J.H., Lam P.K., Richardson B.J. Antibiotics in the Hong Kong metropolitan area: ubiquitous distribution and fate in Victoria Harbour. Mar. Pollut. Bull. 2009, 58:1052-1062.
33. Mimeault C., Trudeau V.L., Moon T.W. Waterborne gemfifrozil challenges the hepatic antioxidant defense system and down-regulates peroxisome proliferator-activated receptor beta (PPARbeta) mRNA levels in male goldfish (Carassius auratus). Toxicology 2006, 228:140-150.
34. Moore M.N., Depledge M.H., Readman J.W., Leonard D.R.P. An integrated biomarker-based strategy for ecotoxicological evaluation of risk in environmental management. Mutat. Res. 2004, 552:247-268.
35. Moore M.N., Allen J.I., McVeigh A. Environmental prognostics: an integrated model supporting lysosomal stress responses as predictive biomarkers of animal health status. Mar. Environ. Res. 2006, 61:278-304.
36. Owen S.F., Giltrow E., Huggett D.B., Hutchinson T.H., Saye J., Winter M.J., Sumpter J.P. Comparative physiology, pharmacology and toxicology of β-blockers: mammals versus fish. Aquat. Toxicol. 2007, 82:145-162.
37. Owen S.F., Huggett D.B., Hutchinson T.H., Hetheridge M.J., Kinter L.B., Ericson J.F., Sumpter J.P. Uptake of propranolol, a cardiovascular pharmaceutical, from water into fish plasma and its effects on growth and organ biometry. Aquat. Toxicol. 2009, 93:217-224.
38. Paetzold S.S., Ross N.W., Richards R.C., Jones M., Hellou J., Bard S.M. Up-regulation of hepatic ABCC2, ABCG2, CYP1A1 and GST in multixenobiotic-resistant killifish (Fundulus heteroclitus) from the Sydney Tar Ponds, Nova Scotia, Canada. Mar. Environ. Res. 2009, 68:37-47.
39. Roberts P., Thomas K.V. The occurrence of selected pharmaceuticals in wastewater effluent and surface waters of the Tyne Estuary. UK and its tributaries. Sci. Total Environ. 2006, 356:143-153.
40. Rohlff C., Glazer R.I. Regulation of multidrug resistance through the cAMP and EGF signalling pathways. Cell Signal. 1995, 7:431-443.
41. Santos L.H., Araújo A.N., Fachini A., Pena A., Delerue-Matos C., Montenegro M.C. Ecotoxicological aspects related to the presence of pharmaceuticals in the aquatic environment. J. Hazard. Mater. 2010, 175:45-95.
42. Shpakov A.O., Shipilov V.N., Bondareva V.M. Sensitivity of adenylyl cyclase signalling system of the mollusk Anodonta cygnea ganglions to serotonin and adrenergic agonists. Ann. N.Y. Acad. Sci. 2005, 1040:466-468.
43. Solé M., Shaw J.P., Frickers P.E., Readman J.W., Hutchinson T.H. Effects of feeding rate and biomarker responses of marine mussels experimentally exposed to propranolol and acetaminophen. Anal. Bioanal. Chem. 2010, 396:649-656.
44. Terman A., Kurz T., Gustafsson B., Brunk U.T. Lysosomal labilization. IUBMB Life 2006, 58:531-539.
45. Thomas K.V., Hilton M.J. The occurrence of selected human pharmaceutical compounds in UK estuaries. Mar. Pollut. Bull. 2004, 49:436-444.
46. Thomas, K.V., Langford, K.H., 2007. Occurrence of pharmaceuticals in the aqueous environment. In: Barcelò, M., Petrovic, D. (Eds.), Analysis, Fate and Removal of Pharmaceuticals in the Water Cycle, Amsterdam, pp. 341-363.
47. Tierney A.J. Structure and function of invertebrate 5-HT receptors: a review. Comp. Biochem. Physiol. A 2001, 128:791-804.
48. UNEP/RAMOGE Manual on Biomarkers Recommended for the MED POL Biomonitoring Programme 1999, UNEP, Athens, 39 pp.
49. Valenti T.W., Perez-Hertado P., Chambliss C.K., Brooks B.W. Aquatic toxicity of sertraline to Pimephelas promelas at environmentally relevant surface water pH. Environ. Toxicol. Chem. 2009, 28:2685-2694.
50. Viarengo A., Lowe D., Bolognesi F., Fabbri E., Koehler A. The use of biomarkers in biomonitoring: a 2-tier approach assessing the level of pollutant-induced stress syndrome in sentinel organisms. Comp. Biochem. Physiol. C 2007, 146:281-300.
51. Weir M.R. Beta-blockers in the treatment of hypertension: are there clinically relevant differences?. Postgrad. Med. 2009, 121:90-98.